Even today, technetium-99m is a radionuclide choice for diagnostic in nuclear medicine. The unique chemical and physical properties of technetium-99m make it suitable as an available radionuclide in many centers. In this study, we examined the potential of CQD as a reducing agent in the MDP kit. Citric acid-derived CQD was synthesized and confirmed by FT-IR, TEM, UV-Vis, XPS, and surface analysis. No cytotoxicity was observed by the MTT assay. They were reducing properties of the CQD confirmed by fluorescence microscopy. The MDP kit is prepared by evaluating different parameters that affect the radiolabeling yield, including ligand, time, and CQD. The optimum amount of each parameter is obtained by BoxBehnken software. Finally, fluorescent spectroscopy, SPECT imaging, and biodistribution study showed that CQD reduces technetium-99m. Accumulation of radiotracer in the femur showed that CQD could be used in a radiopharmaceutical kit.

Multifunctional nano-contrast agent carriers are redefining molecular imaging by combining high-fidelity visualization with targeted delivery, controlled release, and, increasingly, therapeutic action. This review encompasses the development of nano-contrast platforms from conventional dendrimer, liposome, chitosan, and silica systems to modular nano-contrast platforms for multimodal, multi-parametric, and activatable imaging in clinically relevant environments. We dissect engineering strategies that govern surface chemistry, ligand organization, stimulus responsiveness, and microenvironmental sensing, and relate them to theranostic performance, immune system engagement, and quantitative image readouts. Biodistribution, pharmacokinetics, and safety are discussed from both classical and model-informed perspectives, with design principles that favor predictable behavior, manufacturability, and regulatory acceptance. Current clinical translation, regulatory pathway evolution, and market dynamics are critically reviewed to elucidate that a few nano-contrast agents have reached patients despite a widespread experimental landscape. Finally, we discuss emerging trends, including biomimetic and ultrasmall carriers, metal–organic and hybrid frameworks, AI-assisted design, digital twins, and precision medicine workflows, which are likely to shape the next-generation nano-contrast theranostics. By systematically relating material selection and carrier architecture to imaging function and translational limitations, this review suggests concrete research priorities for taking nano-contrast agents from sophisticated prototypes to robust, patient-tailored tools.

Introduction. Breast cancer is the leading cause of mortality for women, and effort is being made to provide an agent which has both imaging and therapeutic effects (theranostics) which can improve the survival, economic burden, and outcomes. Methods. In this research, for the first time, we introduce a new magnetophotoluminescent quantum dot (Mn‐Si‐QD) capable of DOX loading. Mn‐Si‐QD was synthesized and evaluated by FT‐IR, UV‐Vis, fluorescence, SEM, and TEM. The impacts of various factors such as reaction time and reaction temperature were investigated to reach the optimum fluorescence properties. Toxicity on normal and cancerous cells was evaluated with an MTT assay. Results. The characterization analysis confirmed successful synthesis, and the MTT assay showed no cytotoxicity on normal cells and showed toxicity on cancerous cells. Magnetopotential showed no difference when compared using OmniScan. In vivo fluorescence imaging was considered and indicated the acceptable (25% ID/g) uptake on the tumor region. The biodistribution study also confirmed the accumulation of the magnetophotoluminescent quantum dot in the tumor site. Conclusion. Our research indicated that DOX‐loaded Mn‐Si‐QD is both noninvasive and an agent that can be hopefully used in theranostics.

Dental journal editors, grant providers, research managers, educational planners, and clinical professionals could direct more attention to artificial intelligence and machine learning as a rapid, effective and inexpensive tool to solve complicated clinical problems.